Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

Zymeworks Announces Abstract for Zanidatamab in First-line HER2-Expressing … – The Daily Times,

Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical … well as several Phase 2 clinical trials for HER2-expressing gastroesophageal, …, Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical … well as several Phase 2 clinical trials for HER2-expressing gastroesophageal, …, Read More

Scroll to Top